Jacob D. Soumerai

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells

Philipp Karschnia, Justin T. Jordan, Deborah Forst et al. · Blood · 2019 · 347 citations · Full text

Life Sciences, Immunology, Neurology +16

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

Steven P. Treon, Jorge J. Castillo, Alan P Skarbnik et al. · Blood · 2020 · 333 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +16

Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180

Steven P. Treon, Leukothea Ioakimidis, Jacob D. Soumerai et al. · Journal of Clinical Oncology · 2009 · 290 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Connie Lee Batlevi, Fushen Sha, Anna Alperovich et al. · Blood Cancer Journal · 2020 · 203 citations · Full text

Medicine, Oncology, Hematologic Oncology +13

Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study

Tanya Siddiqi, David G. Maloney, Saad S. Kenderian et al. · The Lancet · 2023 · 198 citations · Full text

Medicine, Oncology, Pharmacology +12